LQDA
Liquidia Corp
NASDAQ · Healthcare · Biotechnology · US
$34.13
−0.64%0
Insider buys (3m)
26
Insider sells (3m)
-$43.7M
Net value (3m)
-55.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 13, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 2,474 | $0.00 |
| Oct 13, 2026 | Saggar Rajeev · officer: Chief Medical Officer | M-Exempt | 4,486 | $0.00 |
| Oct 13, 2026 | Schundler Russell · officer: General Counsel | Sale | 13,692 | $28 |
| Oct 13, 2026 | JEFFS ROGER · director, officer: Chief Executive Officer | M-Exempt | 13,833 | $0.00 |
| Oct 13, 2026 | Schundler Russell · officer: General Counsel | M-Exempt | 3,758 | $0.00 |
| Oct 13, 2026 | Adair Jason · officer: Chief Business Officer | Sale | 7,301 | $28 |
| Oct 13, 2026 | Kaseta Michael · officer: CFO and COO | M-Exempt | 7,049 | $0.00 |
| Oct 13, 2026 | Kaseta Michael · officer: CFO and COO | M-Exempt | 5,828 | $0.00 |
| Oct 13, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 3,868 | $0.00 |
| Oct 13, 2026 | Moomaw Scott · officer: Chief Commercial Officer | M-Exempt | 4,358 | $0.00 |
| Oct 13, 2026 | Moomaw Scott · officer: Chief Commercial Officer | Sale | 8,863 | $28 |
| Oct 13, 2026 | Boyle Dana · officer: Chief Accounting Officer | Sale | 5,892 | $28 |
| Oct 13, 2026 | JEFFS ROGER · director, officer: Chief Executive Officer | M-Exempt | 14,333 | $0.00 |
| Oct 13, 2026 | JEFFS ROGER · director, officer: Chief Executive Officer | Sale | 32,744 | $28 |
| Oct 13, 2026 | Khindri Sanjeev · officer: Chief Development Officer | Sale | 1,101 | $28 |
| Oct 13, 2026 | Moomaw Scott · officer: Chief Commercial Officer | M-Exempt | 3,108 | $0.00 |
| Oct 13, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 3,906 | $0.00 |
| Oct 13, 2026 | Saggar Rajeev · officer: Chief Medical Officer | M-Exempt | 3,530 | $0.00 |
| Oct 13, 2026 | Schundler Russell · officer: General Counsel | M-Exempt | 6,409 | $0.00 |
| Oct 13, 2026 | Boyle Dana · officer: Chief Accounting Officer | M-Exempt | 3,178 | $0.00 |
| Oct 13, 2026 | Kaseta Michael · officer: CFO and COO | Sale | 18,938 | $28 |
| Oct 13, 2026 | Saggar Rajeev · officer: Chief Medical Officer | Sale | 9,218 | $28 |
| Oct 13, 2026 | Krepp Sarah · officer: Chief Human Resource Officer | M-Exempt | 3,178 | $0.00 |
| Oct 13, 2026 | Krepp Sarah · officer: Chief Human Resource Officer | Sale | 5,245 | $28 |
| Oct 7, 2026 | Bloch Stephen M · director | Sale | 235,477 | $27 |
| Sep 15, 2026 | SINGH RAMAN · director | Sale | 9,024 | $69 |
| Sep 15, 2026 | SINGH RAMAN · director | Sale | 8,468 | $66 |
| Sep 15, 2026 | SINGH RAMAN · director | M-Exempt | 556 | $8.63 |
| Sep 15, 2026 | SINGH RAMAN · director | M-Exempt | 8,468 | $9.31 |
| Sep 3, 2026 | Krepp Sarah · officer: Chief Human Resource Officer | Sale | 274 | $68 |
Institutional positioning
13F filings over the trailing two quarters
New 188Increased 185Reduced 170Sold out 40
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 10,788,586 | Aug 7, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 8,656,038 | May 15, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 8,365,038 | Aug 14, 2026 |
| Caligan Partners LP | Unchanged | 8,118,892 | Aug 14, 2026 |
| CALIGAN PARTNERS LP | Unchanged | 8,118,892 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5,489,144 | May 13, 2026 |
| FINDELL CAPITAL MANAGEMENT LLC | Increased | 4,802,212 | Aug 14, 2026 |
| FINDELL CAPITAL MANAGEMENT LLC | Reduced | 3,552,112 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,139,183 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 3,030,395 | Sep 22, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,926,945 | May 15, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 2,545,000 | May 15, 2026 |
| Opaleye Management Inc. | Reduced | 2,447,500 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 2,287,792 | May 18, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2,121,290 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 13, 2026